下调和上调
癌基因
MHC I级
分子生物学
生物
抄写(语言学)
基因表达
发起人
肿瘤坏死因子α
β-2微球蛋白
基因
主要组织相容性复合体
癌症研究
免疫学
细胞周期
遗传学
哲学
语言学
作者
Barbara Seliger,Klaus Pfizenmaier
标识
DOI:10.1111/j.1744-313x.1989.tb00477.x
摘要
SUMMARY Transformation of murine NIH3T3 fibroblasts with retroviral vectors carrying the mos, myc and the Ha‐ras oncogene, respectively, was associated with a strong reduction of H2 antigen expression in the cell membrane. Analysis of H‐2K and β 2 ‐microglobulin promoter‐driven CAT activity in these oncogenic transformants and normal NIH3T3 fibroblasts revealed unchanged promoter activity, suggesting post‐transcriptional control of MHC class I expression by these oncogenes. Treatment with IFN‐gamma and TNF‐alpha caused 2‐ to 3‐fold enhancement of H‐2K and β 2 ‐microglobulin promoter activity, as well as a normalization (TNF‐alpha treatment) or enhancement (IFN‐gamma treatment) of H2 membrane expression. These data suggest that IFN‐gamma as well as TNF‐alpha can counteract downregulation of H‐2 genes by interference with an oncogene‐induced, post‐transcriptional block as well as by a direct enhancement of H‐2 gene transcription.
科研通智能强力驱动
Strongly Powered by AbleSci AI